Measles Death Toll Rises as Pennsylvania Faces Severe Outbreak
Pennsylvania's measles outbreak has claimed a fourth life, highlighting a growing public health crisis as vaccination rates decline.
September 15, 2026
Technology
Latest technology news and innovations
RFK Jr. Reconnects with Anti-Vaccine Movement at Health Conference
Robert F. Kennedy Jr. is set to speak at an anti-vaccine conference, marking his first major public appearance with the group since joining HHS.
September 15, 2026
FDA Launches Pilot Program to Accelerate Drug Testing Initiatives
The FDA's new pilot program aims to expedite the initiation of human testing for drugmakers, responding to industry demands for faster processes.
September 15, 2026
Obesity Treatments Being Evaluated for Young Children
Drugmakers are investigating the use of obesity treatments in children as young as six, reflecting a shift in pediatric health approaches.
September 15, 2026
Serious Concerns Emerge Around Medicare's Prior-Authorization Pilot Program
Recent documents highlight significant issues with Medicare's prior-authorization pilot, raising questions about its effectiveness and future rollout.
September 15, 2026
NIH Expands Funding Opportunities for Businesses in Health and Science
Businesses can now apply for NIH funding, broadening access to vital resources for health and science advancements.
September 15, 2026
Investigating the End of America’s Largest Cyclospora Outbreak: Questions Remain
U.S. health officials announce the end of a historic cyclospora outbreak, yet its origin remains uncertain despite extensive investigations.
September 11, 2026
Persistent Cancer Drug Shortages Disrupt Patient Care Across Treatment Centers
Cancer treatment facilities face ongoing drug shortages, complicating patient care and raising concerns over long-term impacts on treatment efficacy.
September 11, 2026
AI Advances in Cardiology: New Tool for Heart Attack Triage Approved
FDA has approved an advanced AI tool to improve triage for heart attack patients, enhancing care during critical events.
September 11, 2026
Oura's Public Filing Highlights Impressive $1.2 Billion Earnings
Oura reveals impressive earnings of $1.2 billion as it prepares for a public offering, positioning itself strongly in the consumer health tech space.
September 08, 2026
AstraZeneca’s New Breast Cancer Drug Receives FDA Approval
AstraZeneca has gained FDA approval for its latest breast cancer medication, marking a significant milestone in oncology treatment.
September 08, 2026
AstraZeneca's Tozorakimab Shows Promise as a New COPD Treatment
AstraZeneca's tozorakimab has significantly reduced COPD flare-ups in late-stage trials, hinting at its potential as a leading treatment option.
September 08, 2026
Inhibrx Achieves Milestone in HPV-Positive Head and Neck Cancer Treatment with OX40 Immunotherapy
Inhibrx reports promising results from its OX40-targeted immunotherapy, especially in HPV-positive head and neck cancer patients, marking a notable industry breakthrough.
September 08, 2026
Roivant's Mosliciguat Shows Promising Results in Mid-Stage Study for Pulmonary Hypertension
Roivant's experimental drug, mosliciguat, demonstrates significant efficacy in a mid-stage trial for pulmonary hypertension, signaling potential new treatment avenues.
September 08, 2026
Novartis' Pelacarsen Fails to Show Efficacy in Key Cardiovascular Trial
The Phase 3 trial for Novartis' cardiovascular drug pelacarsen concluded without significant results, impacting its potential in heart disease treatment.
September 04, 2026
Hope Remains for Angelman Syndrome Treatments Despite Recent Setback
While a drug for Angelman syndrome failed in trials, experts believe other experimental therapies may still hold promise for neurological conditions.
September 04, 2026
FDA Reassesses Botanical Drugs Amid Ongoing Healthcare Challenges
The FDA is revisiting its stance on botanical drugs as hurdles persist for clozapine use and pig kidneys emerge as a potential bridge for transplants.
September 04, 2026
The Health Insurance Risks Faced by Disabled Workers Amid Medicaid Changes
A recent report highlights that disabled workers may face significant health insurance coverage losses as Medicaid work requirements are set to change.
September 04, 2026
Bristol Myers Squibb Halts CAR-T Trials Amid Safety Concerns
Bristol Myers Squibb has paused its CAR-T therapy trials for autoimmunity due to severe side effects, raising questions about transparency.
September 04, 2026
Tension Between CDC and States Complicates Measles Outbreak Response
The conflict over measles death counts between CDC leadership and Pennsylvania undermines public health efforts in addressing the outbreak.
September 04, 2026